M. Pasetti
University of Milano-Bicocca
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. Pasetti.
Radiotherapy and Oncology | 2008
Giovanni Mauro Cattaneo; Italo Dell’Oca; Sara Broggi; Claudio Fiorino; Lucia Perna; M. Pasetti; G. Sangalli; Nadia di Muzio; Ferruccio Fazio; Riccardo Calandrino
BACKGROUND AND PURPOSE To investigate the impact of Helical Tomotherapy (HT) upon the dose distribution when compared to our routinely delivered 3D conformal radiotherapy (CRT) in the case of patients affected by stage III non-small-cell lung cancer (NSCLC). MATERIAL AND METHODS Thirteen stage III inoperable NSCLC patients were scheduled to receive 61.2-70.2Gy, 1.8Gy/fraction. Two treatment techniques (HT and CRT) were considered, and in the case of CRT the dose calculation was performed using both the pencil beam (PB) and Anisotropic Analytical Algorithm (AAA) available on the Varian Eclipse planning system. Dose volume constraints for PTV coverage and OAR sparing were assessed for the HT inverse planning with the highest priority upon PTV coverage and spinal cord sparing. The three plans were compared in terms of dose-volume histograms (DVHs) and normal tissue complication probability (NTCP). A statistical analysis was performed using non-parametric Wilcoxon matched pairs tests. RESULTS In CRT the use of a less accurate algorithm (PB) decreased the monitor unit number by 2.4%. HT significantly improved dose homogeneity within PTV compared with CRT_AAA. For lung parenchyma V20-V40 were lower with HT, corresponding to a decrease of 7% in the risk of radiation pneumonitis. The volume of the heart and esophagus irradiated to >45-60Gy were reduced using HT plans. For eight PTs with an esophagus-PTV overlap >5%, HT significantly reduced both late and acute esophageal complication probability. CONCLUSIONS Our findings obtained in stage III NSCLC patients underline that HT guarantees an important sparing of lungs and esophagus, thus HT has the potential to improve therapeutic ratio, when compared with CRT, by means of dose escalation and/or combined treatment strategy. In CRT of locally advanced lung cancers, the use of a more advanced algorithm would give significantly better modeling of target dose and coverage.
Radiotherapy and Oncology | 2016
C. Sini; C. Fiorino; L. Perna; B. Noris Chiorda; V. Sacco; M. Pasetti; A. Chiara; R. Calandrino; N. Di Muzio; C. Cozzarini
S807 ________________________________________________________________________________ was maintained as long as the effect metric used for Cox regression had a linear correlation with the true effect metric of at least 0.50. The conclusions held if the trial cohort consisted of an expected high benefit population (22% reduced sample size), but the effect was even stronger if the cohort was a population with modest expected benefit (31% reduced sample size).
Clinical Oncology | 2016
N. Di Muzio; A. Fodor; B. Noris Chiorda; S. Broggi; P. Mangili; Riccardo Valdagni; I. Dell'Oca; M. Pasetti; C. Deantoni; A. Chiara; G. Berardi; A. Briganti; R. Calandrino; C. Cozzarini; C. Fiorino
International Journal of Radiation Oncology Biology Physics | 2009
C. Cozzarini; C. Fiorino; F. Alongi; G. Berardi; Angelo Bolognesi; S. Broggi; A.M. Deli; M. Pasetti; Patrizio Rigatti; N. Di Muzio
International Journal of Radiation Oncology Biology Physics | 2009
A. del Vecchio; Micaela Motta; Angelo Bolognesi; M. Pasetti; S. Broggi; L. Rigoni; L. Perna; N. Di Muzio
Radiotherapy and Oncology | 2015
N. Di Muzio; A. Fodor; B. Noris Chiorda; C. Cozzarini; S. Broggi; P. Mangili; Riccardo Valdagni; I. Dell'Oca; M. Pasetti; C. Deantoni; A. Chiara; G. Berardi; A. Briganti; R. Calandrino; C. Fiorino
Radiotherapy and Oncology | 2011
I. Dell'Oca; C. Fiorino; A. Fodor; A. Chiara; Eugenio Villa; W. Casagrande; Alessia Rognone; M. Pasetti; S. Broggi; Elena Busnardo; Claudio Landoni; Luigi Gianolli; R. Calandrino; N. Di Muzio
Radiotherapy and Oncology | 2018
A. Fodor; S. Broggi; Elena Incerti; I. Dell'Oca; C. Fiorino; A.M. Samanes Gajate; P. Passoni; M. Pasetti; Mauro Cattaneo; Luigi Gianolli; R. Calandrino; Maria Picchio; N. Di Muzio
Radiotherapy and Oncology | 2018
F. Zerbetto; Valentino Bettinardi; A.M. Deli; A. Fodor; Paola Mapelli; Elena Incerti; Federico Fallanca; C. Deantoni; M. Pasetti; I. Dell'Oca; A. Chiara; N. Slim; Giacomo Rossi; C. Gumina; Maria Picchio; Angelo Bolognesi; Luigi Gianolli; N. Di Muzio
European Journal of Nuclear Medicine and Molecular Imaging | 2018
Elena Incerti; S. Broggi; A. Fodor; M. Cuzzocrea; A.M. Samanes Gajate; Paola Mapelli; C. Fiorino; I. Dell’Oca; M. Pasetti; Mauro Cattaneo; R. Calandrino; Luigi Gianolli; N. Di Muzio; Maria Picchio